Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02269280
Brief Title: Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)

First Submitted : October 13, 2014
First Submitted that Met QC Criteria : October 16, 2014
First Posted : October 21, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : July 21, 2020
Last Update Posted : July 22, 2020